Horizon Pharma will reportedly make its bid to go public this week in an effort to raise up to $66 million. The company, which develops meds for arthritis and pain, will try and offer 5.5 million shares for between $10 and $12 each. So far this year there has been a rising number of IPOs, but many have been forced to cut their share price as investors steered clear of the kind of high risks associated with biotechnology. Story